Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: my•gone
Active Ingredient: Rizatriptan benzoate 7.265mg equivalent to Rizatriptan 5mg
Dosage Form: Orodispersible tablet
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Pharmathen SA, Attikis, Greece
Product: my•gone
Active Ingredient: Rizatriptan benzoate 14.53mg equivalent to Rizatriptan 10mg
Dosage Form: Orodispersible tablet
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Pharmathen SA, Attikis, Greece
Product: my•gone Emergency
Active Ingredient: Rizatriptan benzoate 7.265mg equivalent to Rizatriptan 5mg
Dosage Form: Orodispersible tablet
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Pharmathen SA, Attikis, Greece
Dated this 4th day of November 2011.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).